foxo4-dri senolytic 2024 study

foxo4-dri senolytic 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Targeting Cellular Senescence in Aging

Name: foxo4-dri senolytic 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Targeting Cellular Senescence in Aging
Brand: aimoneimmobiliare.it
SKU: 83059870633
Price: 29.67 USD
Availability: InStock
Rating: 4.8055 (19 reviews)

Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link

SKU: 83059870633 · From aimoneimmobiliare.it

4.8

USD29.67 USD69.67

Pay in 4 interest-free payments of $7.42 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing All AbMole products are for research use only, cannot be used for human consumption or veterinary use